Can You Have Noonan Syndrome With a Negative Genetic Test?
At a Glance
Yes, a child can have Noonan syndrome with a negative genetic test. Because standard tests miss 10% to 20% of cases due to undiscovered genes, doctors rely on clinical signs like facial features, heart defects, and growth patterns to make a reliable diagnosis.
Yes, a child can absolutely have Noonan syndrome even if their genetic test comes back negative. A negative genetic test does not mean the clinical diagnosis is wrong.
Why Genetic Testing Isn’t Perfect
Noonan syndrome is a genetic condition caused by changes (mutations) in genes that control how the body grows and develops. The condition is part of a group of disorders known as RASopathies. These are caused by changes in the RAS/MAPK signaling pathway, which is a communication pathway inside the body’s cells that tells them how to grow and divide [1].
While genetic testing is highly advanced, it is not flawless. Currently, genetic testing can identify the specific gene mutation in about 80% to 90% of people with Noonan syndrome [2][3][4]. This means that roughly 10% to 20% of people with the condition will receive a negative test result.
There are a few reasons why this happens:
- Undiscovered genes: Science hasn’t yet found all the genes that cause Noonan syndrome. The genetic spectrum of the condition continues to expand as new causative genes are discovered [5][6][7].
- Testing limitations: Standard genetic panels might not detect mutations in rare genes or changes that occur outside of the usual “hotspots” targeted by the test [8][9].
- Overlapping conditions: Noonan syndrome shares physical features with other closely related RASopathies. A negative Noonan syndrome test might happen because a child actually has a different genetic condition that wasn’t covered by the specific testing panel ordered [10][9].
Diagnosis Based on Clinical Signs
Because genetic testing has limitations, Noonan syndrome remains primarily a clinical diagnosis [2][3][4]. This means a specialist (like a geneticist) diagnoses the condition based on the physical signs and symptoms they see in the patient, rather than relying solely on a lab result.
Doctors often use a specialized checklist called the van der Burgt criteria to guide their diagnosis [2][11][9]. This scoring system looks for specific combinations of “major” and “minor” physical features [12].
Features evaluated in the van der Burgt criteria include:
- Facial characteristics: Unique facial features, such as widely spaced eyes, drooping eyelids (ptosis), or low-set ears.
- Heart defects: Specifically pulmonary valve stenosis (a narrowing of the heart valve) or thickening of the heart muscle.
- Growth patterns: Shorter-than-average height or delayed growth [2][11][9].
- Chest shape: An unusual chest shape, such as a sunken or protruding breastbone.
- Family history: Having a close blood relative (like a parent) who also has Noonan syndrome.
If a patient meets enough of these clinical criteria, a specialist can confidently diagnose Noonan syndrome, regardless of what the genetic test shows [2][11][9]. Establishing a clinical diagnosis can sometimes be tricky because the symptoms vary widely from person to person, and facial features can become less obvious as a child grows older [12][13][14].
What a Negative Test Means for Your Family
Having a negative test result does not mean your child’s condition will be more or less severe than someone with a positive test. The severity of Noonan syndrome depends on the individual symptoms your child is experiencing, not the genetic test result.
However, a negative test does change how other family members are evaluated. Because there is no specific gene mutation to test for, identifying the condition in other family members or testing for it during future pregnancies will rely on clinical evaluations rather than simple blood tests. Because new genes are frequently discovered, it is often a good idea to check back with your geneticist every few years to see if new or broader testing, such as whole-exome sequencing, is appropriate [9][4].
Moving Forward with Care
If your child’s doctor diagnosed Noonan syndrome based on clinical signs, that diagnosis is valid. This clinical diagnosis is usually sufficient to qualify your child for necessary medical monitoring protocols, early intervention services, and school accommodations.
The focus of your child’s care should remain on managing their specific symptoms—such as monitoring their heart, supporting their growth, and assisting with development—rather than waiting for a positive genetic test.
Common questions in this guide
Can a child have Noonan syndrome if their genetic test is negative?
Why might a Noonan syndrome genetic test be negative?
How is Noonan syndrome diagnosed without a positive genetic test?
Does a negative genetic test mean my child's Noonan syndrome is less severe?
Should we consider more genetic testing in the future if the first test is negative?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given that the initial genetic test was negative, are there broader tests, like whole-exome sequencing, that we should consider now or in the future?
- 2.Which specific van der Burgt clinical criteria does my child meet that led to this diagnosis?
- 3.Since the test is negative, how confident are you that we are dealing with Noonan syndrome and not a related RASopathy like Costello or CFC syndrome?
- 4.Which specific specialists does my child need to see right away based on their symptoms, and how often should we monitor their heart?
- 5.Without a known gene mutation, how should we evaluate our other children for subtle clinical signs of Noonan syndrome?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (14)
- 1
Novel therapeutic perspectives in Noonan syndrome and RASopathies.
Saint-Laurent C, Mazeyrie L, Yart A, Edouard T
European journal of pediatrics 2024; (183(3)):1011-1019 doi:10.1007/s00431-023-05263-y.
PMID: 37863846 - 2
Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome.
Dahlgren J, Noordam C
Journal of clinical medicine 2022; (11(7)) doi:10.3390/jcm11072034.
PMID: 35407641 - 3
Young children with Noonan syndrome: evaluation of feeding problems.
Draaisma JMT, Drossaers J, van den Engel-Hoek L, et al.
European journal of pediatrics 2020; (179(11)):1683-1688 doi:10.1007/s00431-020-03664-x.
PMID: 32394265 - 4
Noonan syndrome - a new survey.
Tafazoli A, Eshraghi P, Koleti ZK, Abbaszadegan M
Archives of medical science : AMS 2017; (13(1)):215-222 doi:10.5114/aoms.2017.64720.
PMID: 28144274 - 5
Cardiovascular aspects of Noonan syndrome and related disorders.
Zenker M, Wolf CM
Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V 2025; (37(2)):113-124 doi:10.1515/medgen-2025-2010.
PMID: 40207038 - 6
Novel characterization of MRAS mutation-associated Noonan syndrome: Mild adult-onset hypertrophic cardiomyopathy combined with infective endocarditis: A case report.
Mou X, Liu Y, Zhang Y, et al.
Medicine 2026; (105(2)):e46340 doi:10.1097/MD.0000000000046340.
PMID: 41517739 - 7
Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.
Niihori T, Nagai K, Fujita A, et al.
American journal of human genetics 2019; (104(6)):1233-1240 doi:10.1016/j.ajhg.2019.04.014.
PMID: 31130285 - 8
The novel RAF1 mutation p.(Gly361Ala) located outside the kinase domain of the CR3 region in two patients with Noonan syndrome, including one with a rare brain tumor.
Harms FL, Alawi M, Amor DJ, et al.
American journal of medical genetics. Part A 2018; (176(2)):470-476 doi:10.1002/ajmg.a.38569.
PMID: 29271604 - 9
Clinical and Genetic Characterization of Noonan Syndrome in a Romanian Cohort from Transylvania: Details on PTPN11 c.922A>G Variant and Phenotypic Spectrum.
Nazarie FV, Miclea D, Șufană C, et al.
Diagnostics (Basel, Switzerland) 2025; (15(21)) doi:10.3390/diagnostics15212753.
PMID: 41226044 - 10
Clinical overview on RASopathies.
Zenker M
American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(4)):414-424 doi:10.1002/ajmg.c.32015.
PMID: 36428239 - 11
[Clinical practice guidelines for Noonan syndrome].
Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association , Li X, Wang X, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(3)):324-328 doi:10.3760/cma.j.issn.1003-9406.2020.03.017.
PMID: 32128752 - 12
Noonan syndrome.
van der Burgt I
Orphanet journal of rare diseases 2007; (2()):4 doi:10.1186/1750-1172-2-4.
PMID: 17222357 - 13
Unraveling a Genetic Puzzle: Could MAP3K7 Be a Candidate Gene for RASopathies?
Kızılcan Çetin S, Şıklar Z, Aycan Z, et al.
Journal of clinical research in pediatric endocrinology 2026; (18(Suppl 1)):30-36 doi:10.4274/jcrpe.galenos.2024.2024-3-5.
PMID: 39415662 - 14
Complicated ventricular arrhythmia and hematologic myeloproliferative disorder in RIT1-associated Noonan syndrome: Expanding the phenotype and review of the literature.
Aly SA, Boyer KM, Muller BA, et al.
Molecular genetics & genomic medicine 2020; (8(7)):e1253 doi:10.1002/mgg3.1253.
PMID: 32396283
This page is for informational purposes only and does not replace professional medical advice. Always consult your geneticist or pediatrician about your child's specific diagnosis and symptom management.
Get notified when new evidence is published on Noonan syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.